Article
The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis.
Frontiers in immunology - 1 Jan 2021
Yang Bing, Zhou Mingyao, Wu Yunzi, Ma Yuanyuan, Tan Qin, Yuan Wei, Ma Jie
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor characterized by rapid progression, early metastasis, high recurrence, and limited responsiveness to conventional therapies. The 5-year survival rate of PDAC is extremely low (<8%), which lacks effective prognostic evaluation indicators. In this study, we used xCell to analyze infiltrating immune cells in a tumor and through the univariate and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
